You are here

  • Home
  • Archive
  • Volume 30, Issue 12
  • Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study

Article metrics

Article menu
Download PDFPDF
Original research
Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study

 

Online download statistics by month:

Online download statistics by month: October 2020 to April 2024

AbstractFullPdf
Oct 20208233123
Nov 20206263733
Dec 202017058641
Jan 20213882817
Feb 2021210126
Mar 20214291412
Apr 2021226711
May 20213598
Jun 2021833
Jul 20211056
Aug 202118137
Sep 20211298
Oct 202114055
Nov 202111743
Dec 202114872
Jan 202212295
Feb 202212078
Mar 20228945
Apr 202214265
May 202224964
Jun 20228660
Jul 202210131
Aug 202213162
Sep 20229610
Oct 202211265
Nov 202212541
Dec 20228722
Jan 20237630
Feb 202318942
Mar 20239430
Apr 202310200
May 20237064
Jun 20239330
Jul 20237011
Aug 20239640
Sep 20239761
Oct 202310532
Nov 202313680
Dec 20237621
Jan 20247451
Feb 202410001
Mar 20249312
Apr 20248120
Total7907381238